The Business Of Neurotech

The Business Of Neurotech

Adam Fraser
Land Vereinigte Staaten
Sprache EN-US
Folgen 7
Letzte 29.06.2026

The Business of Neurotech is a podcast that explores the commercial side of neuroscience, covering topics like neuromodulation, brain-computer interfaces, and medical devices. Hosted by Adam Fraser, it features interviews with founders, CEOs, venture capitalists, and strategic leaders. The show discusses market maturity, regulatory challenges, and go-to-market strategies for neurotechnology. It is aimed at investors, researchers, and entrepreneurs interested in the business of brain tech.

Folgen

  • Ryan Field Talks Kernel and Neuroscience as a Service 29.06.2026 38Min.
    What does it take to build a brain measurement company from the ground up and turn neuroscience into a scalable service? In this episode of The Business of Neurotech, host Adam Fraser is joined by Ryan Field, CEO of Kernel, to talk about what it means to build brain technology in an emerging market. Adam and Ryan discuss Ryan’s path from electrical engineering and sensing technology into neurotech, and how Kernel has evolved from an early invasive BCI vision into a company focused on non-inva...
  • David Eagleman Talks Media, Startups, and Neuroscience 15.06.2026 41Min.
    How do you turn neuroscience ideas into real businesses without losing sight of the science? In this episode of The Business of Neurotech, host Adam Fraser sits down with neuroscientist, author, podcaster, entrepreneur, and Stanford educator David Eagleman to explore his journey across academia and neurotech startups. David discusses how he shifted from running a traditional neuroscience lab to building ventures in sensory substitution, digital cognitive assessment, and companion robotics, an...
  • Naveen Rao Talks Neurotech Market Dynamics 01.06.2026 42Min.
    Where is neurotech money really flowing, and what do the numbers say about where the industry is heading next? In this episode of The Business of Neurotech, host Adam Fraser sits down with Naveen Rao, founder of Patchwise Labs, curator of Neurotech Futures, and Forbes contributor covering neurotechnology’s impact on business and society. In their conversation, Naveen shares how a career spanning public health, health policy, advocacy, and healthcare analysis led him into neurotech and explain...
  • Mariam Khayretdinova talks EEG, AI and Psychiatry 18.05.2026 39Min.
    What if the future of psychiatry depended less on subjective questionnaires and more on biological data, scalable brain models, and artificial intelligence? In this episode of The Business of Neurotech, host Adam Fraser sits down with Mariam Khayretdinova, Founder and CEO of Brainify.AI, a company building electroencephalography (EEG) foundation models for precision neuroscience. Mariam brings a mix of applied mathematics, technology, psychology, and lived experience to the discussion, drawin...
  • Amy Kruse Talks Venture Investing in Neurotech 04.05.2026 41Min.
    What does it take to turn cutting-edge brain science into real-world impact? In this episode of The Business of Neurotech Podcast, host Adam Fraser is joined by Dr Amy Kruse, General Partner and CIO (Chief Investment Officer) at Satori Neuro, whose career spans neuroscience research, DARPA (Defense Advanced Research Projects Agency) program leadership, and venture investing. Dr Kruse shares how her early work in human performance and neurotechnology revealed both the promise and the limitatio...
  • Keith Murphy Talks Focused Ultrasound and Start-Up Life 27.04.2026 36Min.
    Can focused ultrasound finally make deep brain stimulation scalable, non-invasive, and practical for everyday patients? In this episode of The Business of Neurotech, host Adam Fraser sits down with Keith Murphy, co-founder and CTO of Attune Neurosciences, to explore how his path from behavioural neuroscience and optogenetics led to a company building wearable focused ultrasound technology for brain stimulation. Keith explains how Attune is tackling the commercial limits of clinic-based neurom...
  • Michael Brotherton Talks Neurotech Market Dynamics and Neurotech Investing 22.04.2026 36Min.
    What does it really take to turn neurotechnology into a scalable business? In this episode of The Business of Neurotech, host Adam Fraser sits down with Michael Brotherton, co-founder and managing partner at Dragonfly 44, to explore the capital, strategy, and market forces shaping the sector. Michael talks about his journey from science into investment banking and how this ultimately led him to establish a business specialising in neuroscience and neurotechnology. He then delves into his defi...

Beliebt in

Dieser Podcast erscheint auch in den Podcast-Charts dieser Länder.